Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Porche-Sorbet

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biochemistry|March 15, 2000
Substitution of asparagine for arginine 347 of recombinant factor Xa markedly reduces factor Va bindingA E Rudolph, R Porche-Sorbet, J P Miletich
The Journal of Biological Chemistry|November 23, 2000
Definition of a factor Va binding site in factor XaA E Rudolph, R Porche-Sorbet, J P Miletich
Protein Expression and Purification|August 1, 1997
Expression, purification, and characterization of recombinant human factor XA E Rudolph, M P Mullane, R Porche-Sorbet, et al.
The Journal of Biological Chemistry|November 8, 1996
Factor XSt. Louis II. Identification of a glycine substitution at residue 7 and characterization of the recombinant proteinA E Rudolph, M P Mullane, R Porche-Sorbet, et al.
The Journal of Biological Chemistry|September 21, 2000
Directed glycosylation of human coagulation factor X at residue 333. Insight into factor Va-dependent prothrombin catalysisB C Cook, A E Rudolph, R G Kurumbail, et al.
Clinical Pharmacology and Therapeutics|March 5, 2010
A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African AmericansD Voora, D C Koboldt, C R King, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biochemistry|March 15, 2000
Substitution of asparagine for arginine 347 of recombinant factor Xa markedly reduces factor Va bindingA E Rudolph, R Porche-Sorbet, J P Miletich
The Journal of Biological Chemistry|November 23, 2000
Definition of a factor Va binding site in factor XaA E Rudolph, R Porche-Sorbet, J P Miletich
Protein Expression and Purification|August 1, 1997
Expression, purification, and characterization of recombinant human factor XA E Rudolph, M P Mullane, R Porche-Sorbet, et al.
The Journal of Biological Chemistry|November 8, 1996
Factor XSt. Louis II. Identification of a glycine substitution at residue 7 and characterization of the recombinant proteinA E Rudolph, M P Mullane, R Porche-Sorbet, et al.
The Journal of Biological Chemistry|September 21, 2000
Directed glycosylation of human coagulation factor X at residue 333. Insight into factor Va-dependent prothrombin catalysisB C Cook, A E Rudolph, R G Kurumbail, et al.
Clinical Pharmacology and Therapeutics|March 5, 2010
A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African AmericansD Voora, D C Koboldt, C R King, et al.
Pageof 1